Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 22

Results For "LAC"

1982 News Found

Orange Health records Rs 138 crore revenue at 65% annual growth in FY26
Startup | April 28, 2026

Orange Health records Rs 138 crore revenue at 65% annual growth in FY26

The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities


AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease
Drug Approval | April 28, 2026

AbbVie seeks FDA nod for subcutaneous SKYRIZI induction in Crohn’s disease

The submission is backed by positive results from the Phase 3 AFFIRM study


AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care
News | April 28, 2026

AstraZeneca wins US nod for at-home lupus treatment in major shift for SLE care

The approval was driven by data from the Phase III TULIP-SC trial


Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Sun Pharma to acquire Organon in $11.75 billion all-cash deal
News | April 27, 2026

Sun Pharma to acquire Organon in $11.75 billion all-cash deal

Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally


Umang Vohra appointed Executive Chairman and Group CEO of Cohance Lifesciences
People | April 27, 2026

Umang Vohra appointed Executive Chairman and Group CEO of Cohance Lifesciences

Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role


Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement
Public Health | April 25, 2026

Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement

The summit brought together over 150 doctors, researchers, and practitioners worldwide


Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform
Digitisation | April 25, 2026

Nihilent launches nSEPIA Beta, introduces AI-driven emotional wellness platform

AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade,  Head Bioprocessing, India, Avantor
interviews | April 24, 2026

Local manufacturing, deeper CDMO ties, region-specific solutions remain our top priorities in next 3–5 years: Ganesh Bade, Head Bioprocessing, India, Avantor

Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region